Facts & Figures

HIV

• As of December 31, 2023, the number of people diagnosed and living with HIV who reside in North Carolina (including those initially diagnosed in another state) was 37,490.
• In 2023, 1,410 people were newly diagnosed with HIV population, a rate of 15.5 per 100,000 adult and adolescent population (13 and older).
• The number of people newly categorized as having Stage 3 HIV (AIDS) increased in 2023 (636), similar to 2022 but increased compared to the previous five years (2021: 511). This may be due to diagnoses delayed by the pandemic shutdown.
• There were 2 perinatal (mother-to-child) HIV transmissions documented in 2023.
• People aged 20 to 34 years old had the highest rates of newly diagnosed HIV in 2023 and comprised 56% (N=789) of the newly diagnosed population.
• Among race/ethnicity groups, Black/African Americans represented a majority (52.3%) of all adult/adolescents newly diagnosed with HIV in 2023, with a rate of 39.0 per 100,000 adult/adolescent population.
• Rates among Black/African men have decreased, from 74.8 per 100,000 in 2019 to 65.5 per 100,000 in 2023. Rates among Black/African women are stable.
• The rate of newly diagnosed HIV increased among Hispanic/Latinx people (29.7 per 100,000 in 2023 compared to 25.6 in 2022).

STD

• Chlamydia case numbers have remained steady since 2020; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2023, there were 65,906 cases (rate of 616 cases per 100,000 population).
• Approximately 80% of chlamydia cases in 2023 were among persons aged 15-29 years.
• The rate of gonorrhea was similar in 2023 to 2022; there were 26,382 gonorrhea cases in 2023 (rate of 246.6 cases per 100,000 population).
• Black/African American persons were more affected by gonorrhea, with 64% of gonorrhea cases in 2023 (16,852 cases; rate of 709 cases per 100,000 population); Black/African American persons had 10 times the rate of White persons (rate of 69.7 cases per 100,000 population).
• Early syphilis cases are more frequent among men, but declined in 2023 (2,848 cases in 2023, rate of 54 per 100,000), while early syphilis among women increased slightly in 2023 (934 cases in 2023, rate of 17 per 100,000). Early syphilis cases had increased steadily between 2012 and 2022, but have decreased slightly in 2023 driven by a decrease among men.
• Along with the continued increase of syphilis in women, congenital syphilis is increasing. There were 72 congenital syphilis cases in 2022, including 10 stillbirths or neonatal deaths attributable to congenital syphilis; cases increased 278% compared to 2018.

Hepatitis B/C

• Acute hepatitis B case numbers have declined since 2018; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2023, there were 107 cases (rate of 1.0 cases per 100,000 population).
• Nearly two-thirds (65%) of acute hepatitis B cases in 2023 were among men.
• Reported chronic hepatitis B cases slightly increased in 2023. In 2023, there were 1,072 chronic hepatitis B cases reported (rate of 10.0 cases per 100,000 population).
• Nearly two-thirds (67%) of chronic hepatitis B cases reported in 2023 were among persons 40 years and older.
• Acute hepatitis C cases slightly increased in 2023; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2023, there were 79 cases (rate of 0.7 cases per 100,000 population).
• More than half (57%) of acute hepatitis C cases in 2023 were among people aged 30-44 years.
• Reported chronic hepatitis C cases slightly decreased in 2023; cases have not rebounded to pre-pandemic levels, possibly due to decreased testing. In 2023, there were 9.427 chronic hepatitis C cases reported (rate of 88.1 cases per 100,000 population).
• Nearly two-thirds (65%) of chronic hepatitis C cases reported in 2023 were among men.